Blocking Protein Ant2 Enhances Immune System's Ability to Fight Cancer
Researchers have discovered a method to enhance the immune system's T cells by blocking a protein known as Ant2, which alters how these cells produce and use energy. This transformation makes T cells more active and effective at attacking cancer cells. The study, led by an international team from Hebrew University, Philipps University of Marburg, and the University of Texas MD Anderson Cancer Center, found that disabling Ant2 reprograms T cells' metabolism, improving their endurance and precision in targeting cancer. The research suggests that this metabolic shift can be induced not only through genetic changes but also with drugs, offering potential new treatment strategies for cancer therapy. 
